Adagio Medical Holdings, Inc. (Nasdaq: ADGM) ("Adagio" or "the Company"), a leading innovator in catheter ablation ...

Interim results highlight six-month outcomes for patients treated with the Sphere-9 catheter for sustained monomorphic ventricular tachycardia (VT)Breakthrough device designation granted for use of th ...

Adagio Medical Holdings, Inc. ("Adagio" or "the Company"), a leading innovator in catheter ablation technologies for the treatment of cardiac arrhythmias, today reported six month results from its ...

Adagio Medical reports positive pivotal results for vCLAS Ventricular Ablation System: Laguna Hills, California Tuesday, April 28, 2026, 17:00 Hrs [IST] Adagio Medical Holdings, I ...

High-precision radiation therapy can significantly reduce the number of arrhythmia episodes in critically ill patients with ...

Over the last weekend, Chicago played host to the 2026 edition of the Heart Rhythm Society's annual conference (HRS 2026).

Eugene Braunwald, MD, celebrated as the 'father of modern cardiology,' died at 96, drawing tributes from leading institutions. The day also saw the FDA clear Cellenkos to start a Phase II trial of ...

STOPSTORM Study identifies new treatment option for severely ill patients – UKSH and CAU lead Europe-wide study High-precision radiation therapy can significantly reduce the number of arrhythmia ...

New data on the pulsed-field ablation (PFA) device class debuts at HRS 2026 as the field catches the eye of several large ...

Medtronic announces key Affera clinical study milestones for Sphere-9 and Sphere-360 catheters as global adoption continues: Galway, Ireland Tuesday, April 28, 2026, 11:00 Hrs [IS ...

Abbott (NYSE:ABT) today shared new study findings supporting its pulsed field ablation (PFA) and conduction system pacing ...